No association of the HLA-A2 allele with Alzheimer's disease

被引:18
作者
Araria-Goumidi, L [1 ]
Lambert, JC [1 ]
Cottel, D [1 ]
Amouyel, P [1 ]
Chartier-Harlin, MC [1 ]
机构
[1] Inst Pasteur, INSERM, U508, F-59019 Lille, France
关键词
Alzheimer; human leucocyte antigen-A2; association; genetic; polymorphism; sporadic;
D O I
10.1016/S0304-3940(02)01057-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A possible association of the human leucocyte antigen (HLA)-A2 allele with increased susceptibility to Alzheimer's disease (AD) has been the subject of debate for more than 20 years. We compared the presence of the HLA-A2allele in a sample from the French population composed of 451 patients and 477 controls. There was no evidence of an association of this allele with increased risk of AD. Moreover, no effect was observed when we stratified the case-control sample on gender, age of onset or presence of an APOE epsilon4 allele. We conclude that HLA-A2 allele is not a major risk factor for sporadic AD. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 19 条
  • [1] Ballerini C, 1999, ANN NEUROL, V45, P397, DOI 10.1002/1531-8249(199903)45:3<397::AID-ANA18>3.0.CO
  • [2] 2-4
  • [3] Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population
    Harris, JM
    Cumming, AM
    Craddock, N
    St Clair, D
    Lendon, CL
    [J]. NEUROSCIENCE LETTERS, 2000, 294 (01) : 37 - 40
  • [4] JIANG HX, 1994, J IMMUNOL, V152, P5050
  • [5] A full genome scan for late onset Alzheimer's disease
    Kehoe, P
    Wavrant-De Vrieze, F
    Crook, R
    Wu, WS
    Holmans, P
    Fenton, I
    Spurlock, G
    Norton, N
    Williams, H
    Williams, N
    Lovestone, S
    Perez-Tur, J
    Hutton, M
    Chartier-Harlin, MC
    Shears, S
    Roehl, K
    Booth, J
    Van Voorst, W
    Ramic, D
    Williams, J
    Goate, A
    Hardy, J
    Owen, MJ
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (02) : 237 - 245
  • [6] HLA class I, II & III genes in confirmed late-onset Alzheimer's disease
    Lehmann, DJ
    Wiebusch, H
    Marshall, SE
    Johnston, C
    Warden, DR
    Morgan, K
    Schappert, K
    Poirier, J
    Xuereb, J
    Kalsheker, N
    Welsh, KI
    Smith, AD
    [J]. NEUROBIOLOGY OF AGING, 2001, 22 (01) : 71 - 77
  • [7] Marx Florentine, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P205
  • [8] Association between polymorphism in regulatory region of gene encoding tumour necrosis factor α and risk of Alzheimer's disease and vascular dementia:: a case-control study
    McCusker, SM
    Curran, MD
    Dynan, KB
    McCullagh, CD
    Urquhart, DD
    Middleton, D
    Patterson, CC
    McIlroy, SP
    Passmore, AP
    [J]. LANCET, 2001, 357 (9254) : 436 - 439
  • [9] The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
    McGeer, PL
    McGeer, EG
    [J]. BRAIN RESEARCH REVIEWS, 1995, 21 (02) : 195 - 218
  • [10] Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
    McGeer, PL
    Schulzer, M
    McGeer, EG
    [J]. NEUROLOGY, 1996, 47 (02) : 425 - 432